GD2-specific CAR T cell therapies for pediatric solid cancers

被引：0
|
作者：
Rossig, Claudia
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 17期
关键词：
D O I：
10.1158/1538-7445.PEDIATRIC24-IA015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA015
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The CARPETS trial: GD2-specific CAR T cell therapy for advanced metastatic melanoma
    Gargett, T.
    Yu, W.
    Dotti, G.
    Yvon, E.
    Christo, S.
    Hayball, J.
    Lewis, I
    Brenner, M.
    Brown, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 517 - 517
  • [2] IN VITRO STUDIES IN SUPPORT OF GD2-SPECIFIC CAR-T CELL THERAPY FOR AGGRESSIVE ADULT AND PEDIATRIC BRAIN TUMORS
    Brown, M. P.
    Gargett, T.
    Ebert, L. M.
    Truong, N.
    Sedivakova, K.
    Kollis, P. M.
    Yu, W.
    Yeo, E.
    Vittorio, O.
    Ziegler, D. S.
    CYTOTHERAPY, 2022, 24 (05) : S125 - S125
  • [3] Targeting of Ewing sarcoma by CAR-reengineered GD2-specific T cells
    Kailayangiri, Sareetha
    Altvater, Bianca
    Meltzer, Jutta
    Leuchte, Katharina
    Hotfilder, Marc
    Juergens, Heribert
    Rossig, Claudia
    CANCER RESEARCH, 2011, 71
  • [4] Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers
    Gargett, Tessa
    Truong, Nga T. H.
    Gardam, Bryan
    Yu, Wenbo
    Ebert, Lisa M.
    Johnson, Amy
    Yeo, Erica C. F.
    Wittwer, Nicole L.
    Tapia Rico, Gonzalo
    Logan, Jesikah
    Sivaloganathan, Purany
    Collis, Maria
    Ruszkiewicz, Andrew
    Brown, Michael P.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (05)
  • [5] Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma
    Quintarelli, Concetta
    Del Bufalo, Francesca
    De Ioris, Maria Antonietta
    Guercio, Marika
    Algeri, Mattia
    Pagliara, Daria
    Silvestris, Domenico Alessandro
    Di Nardo, Matteo
    Sinibaldi, Matilde
    Di Cecca, Stefano
    Iaffaldano, Laura
    Manni, Simona
    Fustaino, Valentina
    Garganese, Maria Carmen
    Colafati, Giovanna Stefania
    Bertaina, Valentina
    Becilli, Marco
    Mastronuzzi, Angela
    Fabozzi, Francesco
    Gunetti, Monica
    Iacovelli, Stefano
    Bugianesi, Rossana
    Macchia, Stefania
    Li Pira, Giuseppina
    Cefalo, Maria Giuseppina
    Leone, Giovanna
    Del Baldo, Giada
    De Angelis, Biagio
    Locatelli, Franco
    NATURE MEDICINE, 2025, : 849 - 860
  • [6] Developing CAR T-Cell Therapies for Pediatric Solid Tumors
    Canciani, Gabriele
    Fabozzi, Francesco
    Pinacchio, Claudia
    Ceccarelli, Manuela
    del Bufalo, Francesca
    PEDIATRIC DRUGS, 2025, 27 (01) : 5 - 18
  • [7] Combination Therapy of GD2-Specific CAR-T Cells with Tyrosine Kinase Inhibitors for Neuroblastoma
    Tomida, Akimasa
    Yagyu, Shigeki
    Yamashima, Kumiko
    Kubo, Hiroshi
    Iehara, Tomoko
    Nakamura, Kayoko
    Nakazawa, Yozo
    Hosoi, Hajime
    MOLECULAR THERAPY, 2020, 28 (04) : 146 - 146
  • [8] GD2-specific CAR T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve vision
    Wang, Kai
    Chen, Yuhui
    Ahn, Sarah
    Zheng, Min
    Landoni, Elisa
    Dotti, Gianpietro
    Savoldo, Barbara
    Han, Zongchao
    NATURE CANCER, 2020, 1 (10) : 990 - +
  • [9] GD2-specific CAR T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve vision
    Kai Wang
    Yuhui Chen
    Sarah Ahn
    Min Zheng
    Elisa Landoni
    Gianpietro Dotti
    Barbara Savoldo
    Zongchao Han
    Nature Cancer, 2020, 1 : 990 - 997
  • [10] BRAF and MEK Inhibition Variably Affect GD2-specific Chimeric Antigen Receptor (CAR) T-Cell Function In Vitro
    Gargett, Tessa
    Fraser, Cara K.
    Dotti, Gianpietro
    Yvon, Eric S.
    Brown, Michael P.
    JOURNAL OF IMMUNOTHERAPY, 2015, 38 (01) : 12 - 23
12345